Management of Worsening Depression and Suicidal Ideation

Assessment and Management Approach

The American College of Physicians, as reported in the Annals of Internal Medicine, recommends that worsening depression and emergence of suicidal ideation during antidepressant or antipsychotic treatment requires immediate attention and modification of the treatment plan 1
Suicidal ideation typically requires prompt intervention, especially when it emerges or worsens during pharmacotherapy, according to the Annals of Internal Medicine and Depression and Anxiety 1, 2
Medication-induced worsening of depression with suicidal ideation represents a serious adverse effect that necessitates treatment modification rather than dose increase, as stated in the Annals of Internal Medicine 3

Increasing the dose of a medication that appears to be causing or associated with worsening depression and suicidal ideation could potentially exacerbate these symptoms, according to the Journal of the American Academy of Child and Adolescent Psychiatry 4
When patients experience significant adverse psychiatric effects from a medication, the appropriate response is typically to modify treatment rather than increase the dose, as recommended by the Annals of Internal Medicine 3

The American Academy of Child and Adolescent Psychiatry suggests assessing suicide risk thoroughly and considering hospitalization if there is imminent risk 1
The Journal of the American Academy of Child and Adolescent Psychiatry recommends not increasing the Caplyta dose as this may worsen the current symptoms 4
The Annals of Internal Medicine suggests considering adding an adjunctive medication with established efficacy for depression 3
Consider adding a second-generation antidepressant based on adverse effect profiles, cost, and patient preferences, as recommended by the Annals of Internal Medicine 3
For rapid relief of suicidal ideation in severe cases, ketamine infusion could be considered under appropriate supervision, which has shown rapid improvement of suicidal ideation within 24 hours, according to the Annals of Internal Medicine 1

The Annals of Internal Medicine and the Journal of the American Academy of Child and Adolescent Psychiatry recommend assessing patient status, therapeutic response, and adverse effects within 1-2 weeks of any medication change 3, 4
Monitor closely for the first 1-2 weeks after treatment modification, as this is when suicide risk may be highest, as stated in the Annals of Internal Medicine 3
If depression and suicidal ideation do not improve within 6-8 weeks of intervention, further modify the treatment approach, according to the Annals of Internal Medicine 3

The Annals of Internal Medicine recommends that if symptoms persist despite adjunctive treatment, consider transitioning to a different primary antipsychotic or antidepressant 3
For severe, persistent suicidal ideation, more intensive interventions such as electroconvulsive therapy may be warranted, according to Depression and Anxiety 2